Mary Deboos

I'm at my happiest helping teams to find actionable insights and new solutions that drive growth, both growth of brands and growth of people.

Prior to OxfordSM I was a Global Insights Director at AstraZeneca covering everything from early Oncology pipeline products through to major launched brands (at that time) such as Crestor, Seroquel and Symbicort.

When I'm not working, you'll find me exploring the natural world around me with family and friends.

Arrange a meeting with Mary

"I'm a Pharmaceutical Industry Specialist who thrives on problem solving."

mary.deboos@oxfordsm.com

Articles by Mary

6 minute read —

The emerging use of AI in Neurology to drive accurate diagnosis

It’s clear that AI is an ever-evolving technology that has wonderful applications. However, AI inherently relies on large, high quality, complete collections of data, and in Pharma those can be harder to find than perhaps you might expect.

3 minute read —

How a portfolio brings added value to Pharma

The company behind a range of pharmacological therapies is often less well known. This creates a particular challenge when trying to understand and quantify the added value having a portfolio of brands, treating one specific disease, brings to a company.

Clinical Thought Leaders have feelings too

The Pharma industry works with Clinical Thought Leaders to understand remaining unmet needs, analyse data, and design and develop new drugs and new clinical trials. Their first-hand experience and wealth of knowledge is vital to drug development. However..

Purpose, a route to regaining trust in Big Pharma

As an industry, since its roots, Pharmaceuticals has devoted itself to creating products and brands that transform patients’ lives. From vaccines that eliminate diseases, improved treatments for cancer and drugs that significantly reduce the risk of heart attacks and stroke, Pharma has much to be proud of. And yet, many people don’t trust Pharma.